134 related articles for article (PubMed ID: 9176276)
1. Cardiac inotropic actions of urocortin in conscious sheep.
Parkes DG; Vaughan J; Rivier J; Vale W; May CN
Am J Physiol; 1997 May; 272(5 Pt 2):H2115-22. PubMed ID: 9176276
[TBL] [Abstract][Full Text] [Related]
2. ACTH-suppressive and vasodilator actions of adrenomedullin in conscious sheep.
Parkes DG; May CN
J Neuroendocrinol; 1995 Dec; 7(12):923-9. PubMed ID: 8745270
[TBL] [Abstract][Full Text] [Related]
3. Direct cardiac and vascular actions of adrenomedullin in conscious sheep.
Parkes DG; May CN
Br J Pharmacol; 1997 Mar; 120(6):1179-85. PubMed ID: 9134233
[TBL] [Abstract][Full Text] [Related]
4. Cardiovascular effects of long-term central and peripheral administration of urocortin, corticotropin-releasing factor, and adrenocorticotropin in sheep.
Weisinger RS; Blair-West JR; Burns P; Denton DA; Purcell B; Vale W; Rivier J; Weisinger HS; May CN
Endocrinology; 2004 Dec; 145(12):5598-604. PubMed ID: 15319360
[TBL] [Abstract][Full Text] [Related]
5. Cardiovascular actions of adrenomedullin in conscious sheep.
Parkes DG
Am J Physiol; 1995 Jun; 268(6 Pt 2):H2574-8. PubMed ID: 7611508
[TBL] [Abstract][Full Text] [Related]
6. Four-day urocortin-I administration has sustained beneficial haemodynamic, hormonal, and renal effects in experimental heart failure.
Rademaker MT; Charles CJ; Espiner EA; Frampton CM; Lainchbury JG; Richards AM
Eur Heart J; 2005 Oct; 26(19):2055-62. PubMed ID: 15961410
[TBL] [Abstract][Full Text] [Related]
7. Beneficial hemodynamic, endocrine, and renal effects of urocortin in experimental heart failure: comparison with normal sheep.
Rademaker MT; Charles CJ; Espiner EA; Fisher S; Frampton CM; Kirkpatrick CM; Lainchbury JG; Nicholls MG; Richards AM; Vale WW
J Am Coll Cardiol; 2002 Oct; 40(8):1495-505. PubMed ID: 12392842
[TBL] [Abstract][Full Text] [Related]
8. Effect of urocortin 1 infusion in humans with stable congestive cardiac failure.
Davis ME; Pemberton CJ; Yandle TG; Lainchbury JG; Rademaker MT; Nicholls MG; Frampton CM; Richards AM
Clin Sci (Lond); 2005 Oct; 109(4):381-8. PubMed ID: 15882144
[TBL] [Abstract][Full Text] [Related]
9. Urocortin is not a significant regulator of intermittent electrofootshock-induced adrenocorticotropin secretion in the intact male rat.
Turnbull AV; Vaughan J; Rivier JE; Vale WW; Rivier C
Endocrinology; 1999 Jan; 140(1):71-8. PubMed ID: 9886809
[TBL] [Abstract][Full Text] [Related]
10. Urocortin 2 acts centrally to delay gastric emptying through sympathetic pathways while CRF and urocortin 1 inhibitory actions are vagal dependent in rats.
Czimmer J; Million M; Taché Y
Am J Physiol Gastrointest Liver Physiol; 2006 Mar; 290(3):G511-8. PubMed ID: 16223946
[TBL] [Abstract][Full Text] [Related]
11. Urocortins: putative role in cardiovascular disease.
Charles CJ; Rademaker MT; Richards AM
Curr Med Chem Cardiovasc Hematol Agents; 2004 Jan; 2(1):43-7. PubMed ID: 15320806
[TBL] [Abstract][Full Text] [Related]
12. Corticotropin-releasing factor alone, but not arginine vasopressin alone, stimulates the release of adrenocorticotropin in the conscious intact sheep.
McFarlane A; Coghlan J; Tresham J; Wintour EM
Endocrinology; 1995 May; 136(5):1821-7. PubMed ID: 7720626
[TBL] [Abstract][Full Text] [Related]
13. Coronary vasodilation and positive inotropism by urocortin in the isolated rat heart.
Terui K; Higashiyama A; Horiba N; Furukawa KI; Motomura S; Suda T
J Endocrinol; 2001 Apr; 169(1):177-83. PubMed ID: 11250659
[TBL] [Abstract][Full Text] [Related]
14. Urocortin 2 infusion in healthy humans: hemodynamic, neurohormonal, and renal responses.
Davis ME; Pemberton CJ; Yandle TG; Fisher SF; Lainchbury JG; Frampton CM; Rademaker MT; Richards AM
J Am Coll Cardiol; 2007 Jan; 49(4):461-71. PubMed ID: 17258092
[TBL] [Abstract][Full Text] [Related]
15. Urocortin, a newly identified corticotropin-releasing factor-related mammalian peptide, stimulates atrial natriuretic peptide and brain natriuretic peptide secretions from neonatal rat cardiomyocytes.
Ikeda K; Tojo K; Sato S; Ebisawa T; Tokudome G; Hosoya T; Harada M; Nakagawa O; Nakao K
Biochem Biophys Res Commun; 1998 Sep; 250(2):298-304. PubMed ID: 9753624
[TBL] [Abstract][Full Text] [Related]
16. The cardiovascular physiologic actions of urocortin II: acute effects in murine heart failure.
Bale TL; Hoshijima M; Gu Y; Dalton N; Anderson KR; Lee KF; Rivier J; Chien KR; Vale WW; Peterson KL
Proc Natl Acad Sci U S A; 2004 Mar; 101(10):3697-702. PubMed ID: 14990799
[TBL] [Abstract][Full Text] [Related]
17. Urocortin, a corticotropin-releasing factor-related mammalian peptide, inhibits edema due to thermal injury in rats.
Turnbull AV; Vale W; Rivier C
Eur J Pharmacol; 1996 May; 303(3):213-6. PubMed ID: 8813571
[TBL] [Abstract][Full Text] [Related]
18. Human urocortin 2, a corticotropin-releasing factor (CRF)2 agonist, and ovine CRF, a CRF1 agonist, differentially alter feeding and motor activity.
Zorrilla EP; Reinhardt LE; Valdez GR; Inoue K; Rivier JE; Vale WW; Koob GF
J Pharmacol Exp Ther; 2004 Sep; 310(3):1027-34. PubMed ID: 15115804
[TBL] [Abstract][Full Text] [Related]
19. Endogenous urocortins reduce vascular tone and renin-aldosterone/endothelin activity in experimental heart failure.
Rademaker MT; Charles CJ; Espiner EA; Frampton CM; Lainchbury JG; Richards AM
Eur Heart J; 2005 Oct; 26(19):2046-54. PubMed ID: 15821006
[TBL] [Abstract][Full Text] [Related]
20. The effects of corticoptropin-releasing factor and the urocortins on striatal dopamine release induced by electrical stimulation-an in vitro superfusion study.
Bagosi Z; Jászberényi M; Bujdosó E; Telegdy G
Neurochem Res; 2006 Feb; 31(2):209-13. PubMed ID: 16518577
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
